Advertisement
Screener

Addex Therapeutics Ltd (ADXN) Expense From Share-based Payment Transactions With Employees

2.8 / 5 stars · 68/120 Roast Me

Addex Therapeutics Ltd Expense From Share-based Payment Transactions With Employees

Addex Therapeutics Ltd (ADXN) reported Expense From Share-based Payment Transactions With Employees of CHF 1.85 thousand for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.

Financial Statements › Expense Statement › Operating Expenses

ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2025-09-30

  • Addex Therapeutics Ltd expense from share-based payment transactions with employees for the quarter ending 2025-06-30 was 1.85K CHF, a 60.63% decline year-over-year.
  • Addex Therapeutics Ltd expense from share-based payment transactions with employees for the quarter ending 2024-06-30 was 4.70K CHF, a 98.87% decline year-over-year.
  • Addex Therapeutics Ltd expense from share-based payment transactions with employees for the quarter ending 2023-06-30 was 416.95K CHF, a 24.22% decline year-over-year.
  • Addex Therapeutics Ltd expense from share-based payment transactions with employees for the quarter ending 2022-06-30 was 550.22K CHF, a 110.83% increase year-over-year.
Period endExpense From Share-based Payment Transactions With Employees 3 monthExpense From Share-based Payment Transactions With Employees 6 monthExpense From Share-based Payment Transactions With Employees 12 monthExpense From Share-based Payment Transactions With Employees 12 month as first filed
2025-06-301.85K CHF
6-K · filed 2025-09-30
4.29K CHF
6-K · filed 2025-09-30
2024-12-3117.54K CHF
20-F · filed 2025-05-15
2024-06-304.70K CHF
6-K · filed 2025-09-30
10.65K CHF
6-K · filed 2025-09-30
2023-12-3129.92K CHF
20-F · filed 2025-05-15
1.52M CHF
20-F · filed 2024-04-18
2023-06-30416.95K CHF
6-K/A · filed 2023-12-21
780.84K CHF
6-K/A · filed 2023-12-21
2022-12-3149.24K CHF
20-F · filed 2025-05-15
3.03M CHF
20-F · filed 2023-03-30
2022-06-30550.22K CHF
6-K/A · filed 2023-12-21
1.71M CHF
6-K/A · filed 2023-12-21
2021-12-31946.63K CHF
20-F · filed 2024-04-18
2021-06-30260.98K CHF
6-K/A · filed 2022-09-14
404.39K CHF
6-K/A · filed 2022-09-14
2020-12-31901.42K CHF
20-F · filed 2023-03-30
2019-12-311.31M CHF
20-F · filed 2022-03-10
2018-12-31719.37K CHF
20-F · filed 2021-03-11
2017-12-3183.46K CHF
20-F · filed 2020-04-27